RESUMEN
OBJECTIVE: Abnormal lipid metabolism plays a role that cannot be ignored in articular cartilage bone marrow lesions, synovial inflammation, and the destruction of chondrocytes (CHs). Ceramide is one of the key constructions of membrane lipid bilayers, which is an intracellular lipid mediator regulating varieties of cellular behaviors. The purpose of this study was to explore the role of ceramide and its inhibitor in the development of the CHs degeneration. PATIENTS AND METHODS: CHs were isolated from the cartilage collecting from the osteoarthritis (OA) patients, and oleic acid/palmitic (O/P) acid was used to induce CHs lipid disordered. Then, myriocin was used to inhibit the accumulation of ceramide. After that, the apoptosis, cell viability, glucose uptake, oxidative stress, and the chondrogenic gene expression were tested to evaluate the degenerated degree of CHs. RESULTS: Results revealed that O/P induced CH apoptosis, ceramide accumulation, a higher level of oxidative stress, IL-1ß and MMP-13, but it also decreased the collagen-â ¡ and SOX-9 expressions and affected the glucose uptake of CHs. After the stimulation of myriocin, the side effects induced by O/P was partly reversed. CONCLUSIONS: O/P induces the accumulation of ceramide and the degeneration of CHs, and myriocin can reject the harmful effect caused by O/P via the suppression of ceramide.
Asunto(s)
Ceramidas/antagonistas & inhibidores , Condrocitos/efectos de los fármacos , Ácidos Grasos Monoinsaturados/farmacología , Ácido Oléico/antagonistas & inhibidores , Palmitatos/antagonistas & inhibidores , Adulto , Anciano , Cartílago Articular/metabolismo , Cartílago Articular/patología , Ceramidas/metabolismo , Condrocitos/metabolismo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Ácido Oléico/farmacología , Osteoartritis/metabolismo , Osteoartritis/patología , Palmitatos/farmacologíaRESUMEN
BACKGROUND: Ceramide plays pathogenic roles in nonalcoholic fatty liver disease (NAFLD) via multiple mechanisms, and as such inhibition of ceramide de novo synthesis in the liver may be of therapeutically beneficial in patients with NAFLD. In this study, we aimed to explore whether inhibition of ceramide signaling by myriocin is beneficial in animal model of NAFLD via regulating autophagy. METHODS: Sprague Dawley rats were randomly divided into three groups: standard chow (n = 10), high-fat diet (HFD) (n = 10) or HFD combined with oral administration of myriocin (0.3 mg/kg on alternate days for 8 weeks) (n = 10). Liver histology and autophagy function were measured. HepG2 cells were incubated with fatty acid with or without myriocin treatment. Lipid accumulation and autophagy markers in the HepG2 cells were analyzed. Serum ceramide changes were studied in 104 subjects consisting healthy adults, liver biopsy-proven patients with NAFLD and liver biopsy-proven patients with chronic hepatitis B (CHB). RESULTS: Myriocin reversed the elevated body weight and serum transaminases and alleviated dyslipidemia in HFD fed rats. Myriocin treatment significantly attenuated liver pathology including steatosis, lobular inflammation and ballooning. By qPCR analysis, it was revealed that myriocin corrected the expression pattern of fatty acid metabolism associated genes including Fabp1, Pparα, Cpt-1α and Acox-2. Further, myriocin also restored the impaired hepatic autophagy function in rats with HFD-induced NASH, and this has been verified in HepG2 cells. Among the sphingolipid species that we screened in lipidomic profiles, significantly increased ceramide was observed in NASH patients as compared to the controls and non-NASH patients, regardless of whether or not they have active CHB. CONCLUSIONS: Ceramide may play an important regulatory role in the autophagy function in the pathogenesis of NASH. Hence, blockade of ceramide signaling by myriocin may be of therapeutically beneficial in NASH. TRIAL REGISTRATION: Registration ID: ChiCTR-DDT-13003983 . Data of registration: 13 May, 2013, retrospectively registered.
Asunto(s)
Autofagia/efectos de los fármacos , Ceramidas/metabolismo , Dislipidemias/tratamiento farmacológico , Ácidos Grasos Monoinsaturados/farmacología , Hipolipemiantes/farmacología , Enfermedad del Hígado Graso no Alcohólico/tratamiento farmacológico , Adulto , Animales , Autofagia/genética , Carnitina O-Palmitoiltransferasa/genética , Carnitina O-Palmitoiltransferasa/metabolismo , Estudios de Casos y Controles , Ceramidas/antagonistas & inhibidores , Dieta Alta en Grasa/efectos adversos , Dislipidemias/etiología , Dislipidemias/genética , Dislipidemias/metabolismo , Proteínas de Unión a Ácidos Grasos/genética , Proteínas de Unión a Ácidos Grasos/metabolismo , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Células Hep G2 , Hepatitis B Crónica/genética , Hepatitis B Crónica/metabolismo , Hepatitis B Crónica/patología , Hepatitis B Crónica/virología , Humanos , Metabolismo de los Lípidos , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Masculino , Persona de Mediana Edad , Enfermedad del Hígado Graso no Alcohólico/etiología , Enfermedad del Hígado Graso no Alcohólico/genética , Enfermedad del Hígado Graso no Alcohólico/metabolismo , Ácido Oléico/antagonistas & inhibidores , Ácido Oléico/farmacología , Oxidorreductasas/genética , Oxidorreductasas/metabolismo , PPAR alfa/genética , PPAR alfa/metabolismo , Ácido Palmítico/antagonistas & inhibidores , Ácido Palmítico/farmacología , Ratas , Ratas Sprague-Dawley , Transducción de Señal/efectos de los fármacosRESUMEN
Resveratrol (RES) possesses anti-inflammatory and anti-oxidant activities, and it can prevent liver lipid metabolism disorders in obese and diabetic individuals. This study elucidated the mechanisms of brain and muscle Arnt-like protein-1 (Bmal1) in the protective effects of RES against liver lipid metabolism disorders. The results indicated that RES ameliorated free fatty acid (FFA)-induced (oleic acid (OA): palmitic acid (PA) = 2:1) glycolipid metabolic disorders in hepatocytes. Simultaneously, RES partially reverted the relatively shallow daily oscillations of FFA-induced circadian clock gene transcription and protein expression in HepG2 cells. RES also attenuated FFA-triggered reactive oxygen species (ROS) secretion and restored mitochondrial membrane potential consumption, as well as the restoration of mitochondrial respiratory complex expression. This study provides compelling evidence that RES controls intracellular lipid metabolic imbalance in a Bmal1-dependent manner. Overall, RES may serve as a promising natural nutraceutical for the regulation of lipid metabolic disorders relevant to the circadian clock.
Asunto(s)
Factores de Transcripción ARNTL/genética , Relojes Circadianos/efectos de los fármacos , Hepatocitos/efectos de los fármacos , Homeostasis/efectos de los fármacos , Metabolismo de los Lípidos/efectos de los fármacos , Resveratrol/farmacología , Factores de Transcripción ARNTL/antagonistas & inhibidores , Factores de Transcripción ARNTL/metabolismo , Animales , Proteínas CLOCK/genética , Proteínas CLOCK/metabolismo , Supervivencia Celular/efectos de los fármacos , Relojes Circadianos/genética , Criptocromos/genética , Criptocromos/metabolismo , Regulación de la Expresión Génica , Células Hep G2 , Hepatocitos/citología , Hepatocitos/metabolismo , Homeostasis/genética , Humanos , Metabolismo de los Lípidos/genética , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Ácido Oléico/antagonistas & inhibidores , Ácido Oléico/farmacología , Ácido Palmítico/antagonistas & inhibidores , Ácido Palmítico/farmacología , Proteínas Circadianas Period/genética , Proteínas Circadianas Period/metabolismo , Cultivo Primario de Células , ARN Interferente Pequeño/genética , ARN Interferente Pequeño/metabolismo , Especies Reactivas de Oxígeno/agonistas , Especies Reactivas de Oxígeno/antagonistas & inhibidores , Especies Reactivas de Oxígeno/metabolismo , Transducción de SeñalRESUMEN
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease and its incidence is rising worldwide. We compared the antioxidant capacity of seventeen flavonoids with their inhibitory effects on oleic acid-induced triglyceride (TG) over-accumulation in HepG2 cells. The results showed significant correlations (P < 0.01) between the inhibition of intracellular TG levels and the suppression effects on reactive oxygen species. Nevertheless, the radical-reducing activities of flavonoids assessed by chemical assays (cyclic voltammetry and Folin-Ciocalteu reagent assay) were poorly correlated with their intracellular TG inhibitory effects. The relationships between structural properties of flavonoids and their inhibitory effects on TG over-accumulation were discussed.
Asunto(s)
Antioxidantes/farmacología , Hígado Graso/prevención & control , Flavonoides/farmacología , Ácido Oléico/antagonistas & inhibidores , Línea Celular , Hígado Graso/metabolismo , Humanos , Técnicas In Vitro , Ácido Oléico/farmacología , Especies Reactivas de Oxígeno/metabolismo , Triglicéridos/metabolismoRESUMEN
OBJECTIVES: Oleic acid has been used to induce acute lung injury (ALI) in animals. In patients with acute respiratory distress syndrome (ARDS), the blood level of oleic acid was increased. The mechanism and therapeutic regimen of ARDS and oleic acid-induced ALI remain undefined. In the present study, we investigated the oleic acid-induced changes in lung variables for the measure of ALI, inflammatory mediators, and neutrophil-derived substances. We evaluated the effects of pretreatment and posttreatment with propofol. DESIGN: Randomized, controlled animal study. SETTING: University research laboratory. SUBJECTS: Fifty adult male Sprague-Dawley rats weighing 250-300 g. INTERVENTIONS: We employed a conscious and unrestrained rat model. Oleic acid at a dose of 100 mg/kg was administered intravenously. Propofol (30 mg/kg) was given by intravenous infusion (6 mg/kg/min for 5 mins) 30 mins before (pretreatment) and 30 mins after (posttreatment) oleic acid. MEASUREMENTS AND MAIN RESULTS: We monitored the arterial pressure, heart rate, and blood gas. The lung weight changes, exhaled nitric oxide, protein concentration in bronchoalveolar lavage, and Evans blue content in lung tissue were determined. The plasma nitrate/nitrite, methylguanidine, cytokines (tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and interleukin-10), neutrophil elastase, myeloperoxidase, malondialdehyde, and sodium- and potassium-activated adenosine triphosphatase (Na+-K+-ATPase) were detected. Histopathological examination of the lung was performed. Oleic acid caused systemic hypotension and severe ALI as evidenced by the increases in the extent of ALI, impairment of pulmonary functions (blood gas variables), and lung pathology. In addition, oleic acid significantly increased inflammatory mediators and neutrophil-derived factors but depressed Na+-K+-ATPase. The inducible nitric oxide synthase was up-regulated. Pre- or posttreatment with propofol was capable of reversing the oleic acid-induced changes and attenuating the extent of ALI. CONCLUSIONS: Oleic acid resulted in sepsis-like responses including ALI, inflammatory reaction, and increased neutrophil-derived factors. It depressed the Na+-K+-ATPase activity but up-regulated inducible nitric oxide synthase. Treatment with propofol abrogated or reversed the oleic acid-induced changes.
Asunto(s)
Modelos Animales de Enfermedad , Hipnóticos y Sedantes/uso terapéutico , Propofol/uso terapéutico , Síndrome de Dificultad Respiratoria/prevención & control , Animales , Hemodinámica/efectos de los fármacos , Hipnóticos y Sedantes/farmacología , Masculino , Ácido Oléico/antagonistas & inhibidores , Ácido Oléico/sangre , Ácido Oléico/toxicidad , Propofol/farmacología , Ratas , Ratas Sprague-Dawley , Síndrome de Dificultad Respiratoria/inducido químicamente , Síndrome de Dificultad Respiratoria/patologíaRESUMEN
Acute respiratory distress syndrome or acute lung injury (ARDS)/(ALI) involve the severe lung injury with pulmonary vascular hyper-permeability and hypoxemia induced by inflammatory reactions. Since ARDS/ALI carries high mortality, the development of new drugs against ARDS/ALI is required. We examined the effect of tranilast, an anti-allergic drug, on vascular hyper-permeability in the lungs and airways, and on hypoxemia, in oleic acid (OA)-induced acute lung injury, an animal model of ARDS/ALI. The increase in pulmonary and airway vascular permeability and the decrease in partial oxygen pressure of arterial blood induced by an intravenous injection of OA were drastically ameliorated by the oral administration of tranilast in a dose-dependent manner. This is the first report to prove that tranilast prevents pulmonary and airway vascular permeability and hypoxemia induced by OA. These results suggest that tranilast may be a candidate drug for the treatment of ARDS/ALI.
Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Síndrome de Dificultad Respiratoria/prevención & control , ortoaminobenzoatos/farmacología , Animales , Permeabilidad Capilar/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Cobayas , Pulmón/irrigación sanguínea , Pulmón/efectos de los fármacos , Masculino , Ácido Oléico/antagonistas & inhibidores , Oxígeno/sangre , Presión Parcial , Síndrome de Dificultad Respiratoria/inducido químicamente , ortoaminobenzoatos/administración & dosificaciónRESUMEN
Data presented in this paper show that the size of the endogenous coenzyme Q (CoQ) pool is not a limiting factor in the activation of mitochondrial glycerophosphate-dependent respiration by exogenous CoQ(3), since successive additions of succinate and NADH to brown adipose tissue mitochondria further increase the rate of oxygen uptake. Because the inhibition of glycerophosphate-dependent respiration by oleate was eliminated by added CoQ(3), our data indicate that the activating effect of CoQ(3) is related to the release of the inhibitory effect of endogenous free fatty acids (FFA). Both the inhibitory effect of FFA and the activating effect of CoQ(3) could be demonstrated only for glycerophosphate-dependent respiration, while succinate- or NADH-dependent respiration was not affected. The presented data suggest differences between mitochondrial glycerophosphate dehydrogenase and succinate or NADH dehydrogenases in the transfer of reducing equivalents to the CoQ pool.
Asunto(s)
Ácidos Grasos no Esterificados/metabolismo , Glicerolfosfato Deshidrogenasa/metabolismo , Mitocondrias/enzimología , Ubiquinona/farmacología , Tejido Adiposo Pardo/metabolismo , Animales , Bovinos , Cricetinae , Citocromos c/metabolismo , Activación Enzimática/efectos de los fármacos , Glicerolfosfato Deshidrogenasa/antagonistas & inhibidores , Glicerofosfatos/metabolismo , Masculino , Mesocricetus , Mitocondrias/efectos de los fármacos , NAD/metabolismo , NADH Deshidrogenasa/metabolismo , Ácido Oléico/antagonistas & inhibidores , Ácido Oléico/farmacología , Consumo de Oxígeno/efectos de los fármacos , Consumo de Oxígeno/fisiología , Albúmina Sérica Bovina/farmacología , Succinato Citocromo c Oxidorreductasa/metabolismo , Ácido Succínico/metabolismo , Ubiquinona/metabolismo , Vitamina K 3/farmacologíaRESUMEN
Studies on the gastric proton pump are mostly performed on the H(+), K(+)-ATPase enzyme in the microsomal preparation or by aminopyrine accumulation in the gastric parietal cells. H(+), K(+)-ATPase activity is estimated by both spectrophotometric and fluorimetric methods. In the present study, quenching or augmentation in acridine orange (AO) fluorescence was monitored on a flowcytometer in rat gastric mucosal cells. Rat gastric mucosal cells were isolated by the standard pronase--EDTA method. The effect of oleic acid, a proton pump inhibitory was evaluated on gastric parietal cell activity and was compared with its effect on proton transport, H(+), K(+)-ATPase, and p-nitrophenyl phosphatase (p-NPPase) activity in gastric microsomes. In addition, the effect of histamine and carbachol, gastric acid release inducers, was also investigated by flowcytometry in isolated parietal cells. Histamine and carbachol, in a dose-dependent manner, stimulated acid release from isolated gastric cells. Oleic acid also dose-dependently inhibited the basal and stimulated acid release from the cells, as well as in all three enzyme preparations associated with gastric proton pump activity. Thus, the results suggest that flowcytometric method might be used to study basal, as well as stimulated, proton pump activity in isolated gastric parietal cells.
Asunto(s)
Citometría de Flujo/métodos , Ácido Gástrico/metabolismo , Mucosa Gástrica/efectos de los fármacos , 4-Nitrofenilfosfatasa/metabolismo , Animales , Carbacol/antagonistas & inhibidores , Células Cultivadas , Mucosa Gástrica/citología , Mucosa Gástrica/metabolismo , ATPasa Intercambiadora de Hidrógeno-Potásio/metabolismo , Antagonistas de los Receptores Histamínicos , Técnicas In Vitro , Microsomas , Ácido Oléico/antagonistas & inhibidores , Células Parietales Gástricas/metabolismo , Bombas de Protones/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Estómago/enzimologíaRESUMEN
Olive oil degradation by the thermophilic lipolytic strain Bacillus thermoleovorans IHI-91 in chemostat and batch culture was modeled to obtain a general understanding of the underlying principles and limitations of the process and to quantify its stoichiometry. Chemostat experiments with olive oil as the sole carbon source were successfully described using the Monod chemostat model extended by terms for maintenance requirements and wall growth. Maintenance requirements and biomass yield coefficients were in the range reported for mesophiles. For a chemostat experiment at D = 0.3 h(-1) the model was validated up to an olive oil feed concentration of about 3.0 g L(-1) above which an inhibitory effect occurred. Further analysis showed that the liberated oleic acid is the main cause for this inhibition. Using steady-state oleic acid concentrations measured in chemostat experiments with olive oil as substrate it was possible to derive a kinetic expression for oleic acid utilization, showing that a concentration of 430 mg L(-1) leads to a complete growth inhibition. Oleic acid accumulation observed during batch fermentations can be predicted using a model involving growth-associated lipase production and olive oil hydrolysis. Simulations confirmed that this accumulation is the cause for the sudden growth cessation occurring in batch fermentations with higher olive oil start concentrations. Further, an oscillatory behavior, as observed in some chemostat experiments, can also be predicted using the latter model. This work clearly demonstrates that thermophilic lipid degradation by Bacillus thermoleovorans IHI-91 is limited by long-chain fatty acid beta-oxidation rather than oil hydrolysis.
Asunto(s)
Bacillus/fisiología , Técnicas de Cultivo de Célula/métodos , Ácido Oléico/antagonistas & inhibidores , Aceites de Plantas/metabolismo , Biomasa , Dióxido de Carbono/metabolismo , Medios de Cultivo/metabolismo , Diglicéridos/análisis , Relación Dosis-Respuesta a Droga , Glicéridos/análisis , Hidrólisis , Cinética , Lipasa/metabolismo , Lípidos/análisis , Modelos Teóricos , Aceite de Oliva , Oxígeno/metabolismo , Trioleína/análisisRESUMEN
Rats maintained on low-fat (LF) or high-fat (HF) diets were fitted with gastric cannulas and duodenal catheters. Intraperitoneal injection of 0.250-2.0 microg/kg cholecystokinin (CCK) significantly inhibited gastric emptying of a 5-ml NaCl load in LF rats by 26.2-55. 1% compared with emptying after vehicle injection. By contrast, CCK-induced inhibition of gastric emptying was significantly less in HF rats given the same CCK doses (10.0-31.7% inhibition over the same CCK dose range). A 20-min intraduodenal infusion of oleate (0.03 or 0.06 kcal/ml) also resulted in significant inhibition of gastric emptying in LF rats (24 and 89%, respectively). Oleate-induced inhibition of gastric emptying was significantly attenuated in rats maintained on the HF diet (2 and 56%, respectively). Unlike CCK injections or oleate infusion, intraduodenal maltotriose infusion inhibited gastric emptying to a similar degree in LF and HF rats (77 and 78%, respectively). These results indicate that feeding HF diets diminishes the enterogastric inhibition of gastric emptying by intestinal oleate and diminishes the ability of CCK to inhibit gastric emptying.
Asunto(s)
Adaptación Fisiológica , Colecistoquinina/farmacología , Grasas de la Dieta/administración & dosificación , Vaciamiento Gástrico/efectos de los fármacos , Intestinos/fisiología , Ácido Oléico/farmacología , Animales , Colecistoquinina/antagonistas & inhibidores , Grasas de la Dieta/farmacología , Masculino , Ácido Oléico/antagonistas & inhibidores , Ratas , Ratas Sprague-Dawley , Cloruro de Sodio/farmacologíaRESUMEN
We have previously reported that hydrogen peroxide (H2O2) induced a considerable increase of phospholipase D (PLD) activity and phosphorylation of mitogen-activated protein (MAP) kinase in PC12 cells. H2O2-induced PLD activation and MAP kinase phosphorylation were dose-dependently inhibited by a specific MAP kinase kinase inhibitor, PD 098059. In contrast, carbachol-mediated PLD activation was not inhibited by the PD 098059 pretreatment whereas MAP kinase phosphorylation was prevented. These findings indicated that MAP kinase is implicated in the PLD activation induced by H2O2, but not by carbachol. In the present study, H2O2 also caused a marked release of oleic acid (OA) from membrane phospholipids in PC12 cells. As we have previously shown that OA stimulates PLD activity in PC12 cells, the mechanism of H2O2-induced fatty acid liberation and its relation to PLD activation were investigated. Pretreatment of the cells with methylarachidonyl fluorophosphonate (MAFP), a phospholipase A2 (PLA2) inhibitor, almost completely prevented the release of [3H]OA by H2O2 treatment. From the preferential release of OA and sensitivity to other PLA2 inhibitors, the involvement of a Ca2+-independent cytosolic PLA2-type enzyme was suggested. In contrast to OA release, MAFP did not inhibit PLD activation by H2O2. The inhibitory profile of the OA release by PD 098059 did not show any correlation with that of MAP kinase. These results lead us to suggest that H2O2-induced PLD activation may be mediated by MAP kinase and also that H2O2-mediated OA release, which would be catalyzed by a Ca2+-independent cytosolic PLA2-like enzyme, is not linked to the PLD activation in PC12 cells.
Asunto(s)
Proteínas Quinasas Dependientes de Calcio-Calmodulina/fisiología , Carbacol/farmacología , Peróxido de Hidrógeno/farmacología , Fosfolipasa D/metabolismo , Animales , Ácidos Araquidónicos/farmacología , Activación Enzimática/fisiología , Inhibidores Enzimáticos/farmacología , Flavonoides/farmacología , Glicerofosfolípidos/biosíntesis , Ácido Oléico/antagonistas & inhibidores , Ácido Oléico/fisiología , Organofosfonatos , Células PC12/efectos de los fármacos , Células PC12/enzimología , RatasRESUMEN
Competition for uptake between long-chain free fatty acids has been difficult to document, because there has been no algorithm for computing unbound concentrations of two fatty acids simultaneously in solution with albumin. We modified an iterative procedure to permit this computation and studied initial [3H]oleate uptake by isolated hepatocytes and steady-state uptake by the single-pass perfused rat liver from 600 microM bovine serum albumin solutions containing various concentrations of oleate in the presence and absence of palmitate. In both systems, the Michaelis-Menten constant was significantly higher in the presence of palmitate than in its absence, whereas the maximal reaction velocity was unaltered, indicating competitive inhibition. In additional experiments employing the multiple transhepatic indicator-dilution technique, the influx rate constant and permeability-surface area product for oleate influx were significantly reduced by palmitate, confirming that the competition observed in the conventional perfused liver studies was at the influx step. Long-chain fatty acid uptake has now been shown to exhibit all the kinetic properties of facilitated transport and cannot be attributed solely to passive diffusion.